The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 56 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 28 of 47 cases over the following month. The odds of a continued upward trend are 60%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.088) is normal, around the industry mean (1.339). P/E Ratio (19.760) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.012) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
GL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 21 of 34 cases where GL's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 62%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GL's RSI Oscillator exited the oversold zone, 9 of 15 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 60%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 37 of 60 cases where GL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 62%.
Following a +2.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where GL advanced for three days, in 217 of 379 cases, the price rose further within the following month. The odds of a continued upward trend are 57%.
The Momentum Indicator moved below the 0 level on October 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GL as a result. In 48 of 106 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 45%.
The Moving Average Convergence Divergence Histogram (MACD) for GL turned negative on October 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 20 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 43%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 39%.
The Aroon Indicator for GL entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 47 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. GL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.995) is normal, around the industry mean (1.339). P/E Ratio (10.444) is within average values for comparable stocks, (19.974). GL's Projected Growth (PEG Ratio) (1.360) is slightly higher than the industry average of (0.463). Dividend Yield (0.008) settles around the average of (0.047) among similar stocks. P/S Ratio (2.251) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNO | GL | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 46 | 5 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 3 | 47 | |
SMR RATING 1..100 | 94 | 85 | |
PRICE GROWTH RATING 1..100 | 39 | 56 | |
P/E GROWTH RATING 1..100 | 15 | 35 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CNO's Valuation (63) in the Life Or Health Insurance industry is in the same range as GL (68) in the null industry. This means that CNO’s stock grew similarly to GL’s over the last 12 months.
CNO's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is somewhat better than the same rating for GL (47) in the null industry. This means that CNO’s stock grew somewhat faster than GL’s over the last 12 months.
GL's SMR Rating (85) in the null industry is in the same range as CNO (94) in the Life Or Health Insurance industry. This means that GL’s stock grew similarly to CNO’s over the last 12 months.
CNO's Price Growth Rating (39) in the Life Or Health Insurance industry is in the same range as GL (56) in the null industry. This means that CNO’s stock grew similarly to GL’s over the last 12 months.
CNO's P/E Growth Rating (15) in the Life Or Health Insurance industry is in the same range as GL (35) in the null industry. This means that CNO’s stock grew similarly to GL’s over the last 12 months.
| CNO | GL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 60% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 62% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 45% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 43% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 57% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 42% |
| Advances ODDS (%) | 2 days ago 63% | 6 days ago 57% |
| Declines ODDS (%) | N/A | 12 days ago 39% |
| BollingerBands ODDS (%) | 2 days ago 62% | 2 days ago 62% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 32% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while GL’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 6 TA indicator(s) are bullish while GL’s TA Score has 4 bullish TA indicator(s).
CNO (@Life/Health Insurance) experienced а +7.92% price change this week, while GL (@Life/Health Insurance) price change was +1.89% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.16%. For the same industry, the average monthly price growth was -0.20%, and the average quarterly price growth was -2.97%.
CNO is expected to report earnings on Feb 09, 2027.
GL is expected to report earnings on Feb 10, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, CNO has been loosely correlated with LNC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CNO jumps, then LNC could also see price increases.
A.I.dvisor indicates that over the last year, GL has been loosely correlated with CNO. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if GL jumps, then CNO could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NUSB | 25.15 | N/A | +0.02% |
| Nuveen Ultra Short Income ETF (NUSB) | |||
| QBKV | 26.96 | N/A | N/A |
| AllianzIM U.S. Small Cap Buffer5 ETF (QBKV) | |||
| STOT | 46.33 | -0.01 | -0.02% |
| State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) | |||
| XLYI | 21.94 | -0.01 | -0.04% |
| State Street Consumer Discretionary Select Sector SPDR Premium Income ETF (XLYI) | |||
| FEZ | 65.22 | -0.17 | -0.26% |
| State Street SPDR EURO STOXX 50 ETF (FEZ) | |||